Stempeutics gets Japan process patent for its stem cell drug Stempeucel

Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary donors; it is used for the treatment of CLI Stempeutics Research, a group company of Manipal Education and Medical Group and a …

[Read the full article here]

Comments are closed.